Response Biomedical Cuts Staff By Two-Thirds, Cites Delayed RAMP 510(k)
This article was originally published in The Gray Sheet
Executive Summary
Response Biomedical will cut its 36-employee workforce by roughly two-thirds and file for bankruptcy protection to sustain operations over the next several months as it continues to pursue FDA clearance of its RAMP diagnostic system.